P59 Systemic disease activity as a driver of neuronal affliction in SLE: a longitudinal study

P59 Systemic disease activity as a driver of neuronal affliction in SLE: a longitudinal study

Bibliographic Details
Main Authors:	Andreas Jönsen, Oskar Hansson, Anders A Bengtsson, Pia C Sundgren, Birgitta Gullstrand, Shorena Janelidze, Kristoffer A Zervides, Elsa Grenmyr, Jessika Nystedt, Petra C Nilsson
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-03-01
Series:	Lupus Science and Medicine

Similar Items

Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus
by: Kristoffer A. Zervides, et al.
Published: (2022-12-01)

O18 Data-driven clustering of cerebrospinal fluid proteome reflects clinical phenotypes of systemic lupus erythematosus
by: Andreas Jönsen, et al.
Published: (2024-03-01)

Serum S100A8/A9 concentrations are associated with neuropsychiatric involvement in systemic lupus erythematosus: a cross-sectional study
by: Kristoffer A. Zervides, et al.
Published: (2022-07-01)

PO.1.13 Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus erythematosus
by: P Nilsson, et al.
Published: (2022-10-01)

Structural Changes on MRI Demonstrate Specific Cerebellar Involvement in SLE Patients—A VBM Study
by: Johan Mårtensson, et al.
Published: (2021-04-01)

Altered white matter microstructure in lupus patients: a diffusion tensor imaging study
by: Jessika Nystedt, et al.
Published: (2018-02-01)

PO.5.110 Plasma levels of osteopontin in SLE
by: M Compagno, et al.
Published: (2022-10-01)

P40 Medial temporal lobe subregion volumes in systemic lupus erythematosus patients
by: Andreas Jönsen, et al.
Published: (2024-03-01)

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217
by: Divya Bali, et al.
Published: (2024-02-01)

MRI BrainAGE demonstrates increased brain aging in systemic lupus erythematosus patients
by: Grégory Kuchcinski, et al.
Published: (2023-10-01)

Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study
by: L. Langensee, et al.
Published: (2022-04-01)

Towards a unified protocol for handling of CSF before β-amyloid measurements
by: Shorena Janelidze, et al.
Published: (2019-07-01)

Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE
by: Ola Nived, et al.
Published: (2020-12-01)

Affliction /
by: 455788 Weldon, Fay
Published: (c199)

Affliction
by: Lim, Cordelia Ni Jie
Published: (2015)

Affliction
by: Toh, Geraldine Shu Yi
Published: (2015)

Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
by: Christian Lood, et al.
Published: (2014-01-01)

Abnormal cerebral hemodynamics and blood-brain barrier permeability detected with perfusion MRI in systemic lupus erythematosus patients
by: T. Salomonsson, et al.
Published: (2023-01-01)

Spiritual Wounding and Affliction
by: Edward Kruk
Published: (2019-04-01)

O4 Clinical characteristics of patients with high SLE-specific and high multitrait polygenic risk – An investigation of SLE risk loci
by: Lars Rönnblom, et al.
Published: (2024-03-01)

Blood‐based biomarkers for Alzheimer's disease
by: Antoine Leuzy, et al.
Published: (2022-01-01)

Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer's disease.
by: Nina Schultz, et al.
Published: (2019-01-01)

PO.1.20 Prognostic biomarkers of organ damage in patients with newly diagnosed SLE
by: D Leonard, et al.
Published: (2022-10-01)

PO.3.53 No evidence of a correlation between serum HCQ concentrations and QTc in SLE
by: K Kultima, et al.
Published: (2022-10-01)

Low Intra-Individual Variation in Mean Platelet Volume Over Time in Systemic Lupus Erythematosus
by: Lina Wirestam, et al.
Published: (2021-04-01)

P77 Identification of a cluster of SLE risk loci associated with levels of multiple blood biomarkers in the general population – Implication for SLE sub-phenotypes
by: Lars Rönnblom, et al.
Published: (2024-03-01)

Cultivated cure, regenerated affliction
by: Aditya Bharadwaj
Published: (2017-09-01)

Chaupadi: The affliction of menses in Nepal
by: Hannah Robinson, BA
Published: (2015-12-01)

An emergent affliction in today’s Egypt
by: Ana Vinea
Published: (2018-04-01)

Everyday afflictions in global context
by: Eileen Moyer, et al.
Published: (2020-11-01)

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
by: Claudia Cicognola, et al.
Published: (2021-03-01)

Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
by: Helena Tydén, et al.
Published: (2019-05-01)

Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus
by: Myriam Martin, et al.
Published: (2017-12-01)

Plasma IAPP-Autoantibody Levels in Alzheimer’s Disease Patients Are Affected by <i>APOE4</i> Status
by: Dovilė Pocevičiūtė, et al.
Published: (2023-02-01)

Systemic affliction of oral focal sepsis
by: Vidya Krishnan
Published: (2012-01-01)

When an affliction doesn’t come alone
by: Alberto Mello e Silva
Published: (2022-06-01)

Applications of fitness function in Pubalgia affliction
by: IONIŢE Cătălin, et al.
Published: (2021-03-01)

Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
by: Christian Lood, et al.
Published: (2015-01-01)

Advance Healthcare Directives and Patients Afflicted with Dementia
by: Andrea Cioffi
Published: (2022-03-01)

Shalom & Eirene: Fully Caring for the Afflicted Person
by: Apolos Landa
Published: (2014-01-01)